Associate Clinical Professor, Medicine, UCSF
| CONTACT | |
|
(415) 353-2421 (appts) Box 0324, UCSF; San Francisco, CA 94143-0324 |
additional websites: |
| EDUCATION | |
|
Olivet College, Olivet, Michigan, B.A., 1978, Chemistry/Biology
|
|
| PROFESSIONAL EXPERIENCE | |
|
1976-1978 |
Instructor, Organic Chemistry Laboratory, Olivet College |
|
1988-1989 |
Clinical Instructor of Medicine, Univ. California, San Francisco |
|
1989-1995 |
Assistant Clinical Professor of Medicine, Univ. California, San Francisco |
|
1996-present |
Associate Clinical Professor of Medicine, Univ. California, San Francisco |
|
1989-Present |
Director, Apheresis and Stem cell Collection Unit, University of California, San Francisco |
| HONORS & AWARDS | |
|
1977 |
Omicron Delta Kappa Leadership Society |
|
1978 |
Alpha Chi Scholarship Society |
|
1978 |
Valedictorian, Olivet College |
|
1982 |
Alpha Omega Alpha Medical Student Honor Society |
|
1982 |
Graduated "with distinction", Univ. Michigan Medical School |
|
1985 |
American Cancer Society Clinical Fellowship Award |
| SELECTED PUBLICATIONS | |
|
Damon LE (1982) Effect of relocation on the elderly. Am Fam Phys 26: 144-148. |
|
|
Damon LE, Cadman EC (1986) Recent advances in combination chemotherapy. Cancer Invest 4:421-444. |
|
|
Damon L, Adams M, Stricker R, Ries C (1987) Intracranial bleeding during treatment with hydroxyl ethyl starch. N Engl J Med 317:964-965 (letter). |
|
|
Damon LE, Cadman EC (1988) Metabolic basis for combination chemotherapy. Pharmacol Ther 38:73-127. |
|
|
Rochlitz CR, Damon LE, Russi MB, Geddes A, Cadman, EC (1988) Cytotoxicity of ketoconazole in malignant cell lines. Cancer Chemother Pharmacol 21:319-322. |
|
|
Damon LE, Cadman EC, Benz C (1989) Enhancement of 5-fluorouracil antitumor effect by the prior administration of methotrexate. Pharmacol Ther 43:155-185. |
|
|
Damon LE, Mass R, Linker CA (1989) The association between high-dose cytosine arabinoside neurotoxicity and renal insufficiency. J Clin Oncol 7:1563-1568. |
|
|
Damon LE, Christensen S, Rochlitz CR, Cadman EC (1989) Sequence-dependent synergistic cytotoxicity between etoposide and fluoropyrimidines. Anticancer Res 9:1761-1768. |
|
|
Damon LE, Plunkett W, and Linker CA (1991) Plasma and cerebrospinal fluid pharmacokinetics of 1-β-D-arabinofuranosylcytosine and 1-β-D-arabinofuranosyluracil following the repeated intravenous administration of high and intermediate dose 1-β-D-arabinofuranosylcytosine. Cancer Res 51:4141-4145. |
|
|
Damon LE (1992) Anemias of chronic disease in the aged: diagnosis and treatment. Geriatrics 47:47-57. |
|
|
Damon LE, Plunkett W, and Linker CA (1992) Plasma and cerebrospinal fluid pharmacokinetics of 1-β-D-arabinofuranosylcytosine and 1-β-D-arabinofuranosyluracil following the repeated intravenous administration of high-and -intermediate-dose 1-β-D-arabinofuranosylcytosine. Cancer Res. 52:3819-3820 (reply to letter to the editor). |
|
|
Thompson CE, Damon LE, Ries CA, and Linker CA (1992) Thrombotic microangiopathies in the 1980's: clinical features, response to treatment, and the impact of the HIV epidemic. Blood 80:1890-1895. |
|
|
Linker CA, Ries CA, Damon LE, Rugo HS, and Wolf JL, (1993). Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood. 81:311-318. |
|
|
Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, and DeMarco T (1993). Cyclosporine induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transpl. 12:440-444. |
|
|
Small EJ, Venook AP, and Damon LE (1993). Gallium avid thymic hyperplasia in an adult following chemotherapy for Hodgkin's disease: a case report and review of the literature. Cancer 72:905-908. |
|
|
Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL (1993). Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update. Semin Oncol 20 (Suppl 4): 40-48. |
|
|
Damon LE, Rugo HS, Ries CA, Linker CA (1994). Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. Leukemia 8:535-541. |
|
|
Rugo HS, Damon LE, Ries CA, Wolf JL, Linker CA (1994). High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma. Progress Clin Biology Research 389: 505-11. |
|
|
Lipschutz JH, Miller T, Yen TSB, Vartannian RK, Graber ML, Damon LE, (1995). Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases. Am J Nephrol 15: 431-435. |
|
|
Damon LE, Rugo HS, Ries CA, Linker CA (1996). Delayed engraftment of 4-hydroperoxyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia. Bone Marrow Transpl 17:93-9. |
|
|
Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW (1996). The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone marrow transplantation. Endoscopy 28:680-5. |
|
|
Zander AR, Kruger W, Kroger N, Damon L, Konigmann M, Berdel WE, Gieseking F, Schafer-Eckart K, Mobus V, Frickhofen N, Wandt H, Illiger HJ, Metzner B, Kolbe K, Wormann B, Trumper L, Huber C, Hossfeld DK, Maass H, Jonat W, for the German GABG-4/EH-93-Study (1996). High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. Bone Marrow Transpl 18 (Suppl 1):S24-25. |
|
|
DeMarco T, Damon LE, Colombe B, Keith F, Chatterjee K, Garovoy M (1997). Successful immunomodulation with intravenous gammaglobulin and cyclophosphamide in an alloimmunized cardiac transplant recipient. J Heart Lung Transpl.16:360-5. |
|
|
Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA (1997). High-dose Ara-C (HDAC) dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol 15:833-839. |
|
|
Damon LE (1997). Increasing survival in invasive breast cancer. Cancer Management Today 2:1-5. |
|
|
Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC Jr, Beer M, Ahmed T (1997). A randomized trial of high vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia. Leukemia 11: 485-489. |
|
|
Linker CA, Ries CA, Damon LE, Rugo HS, and Wolf JL (1998). Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone Marrow Transpl 22:865-872. |
|
|
Books and Book Chapters |
|
|
Rugo HS, Damon LE (1990) Occupational hematology. In Occupational Medicine, Joseph LaDou (ed): Appleton and Lange Medical Publications, East Norwalk, CT. pp 155-169. |
|
|
Damon LE (1994). Immunohematology. In Manual of Allergy and Immunology, Glenn J. Lawlor Jr., Thomas J. Fischer, Daniel Adelman (eds): Little, Brown and Company, Boston/Toronto. pp 353- 380. |
|
|
Small EJ and Damon LE (1996) Blood. In Geriatrics, Lonergan ET (ed): Appleton and Lange, Stamford, CT. pp 262-287. |
|
|
Rugo HS, Damon LE (1997) Occupational hematology. In Occupational & Environmental Medicine, Joseph LaDou (ed): Appleton & Lange, Stamford, CT. pp 204-220. |
|
|
Ignoffo RJ, Viele CS, Damon LE, Venook A (eds) (1997). Cancer Chemotherapy Pocket Guide. Lippincott-Raven Publishers |
|
|
2/1/05 |
|


